Related references
Note: Only part of the references are listed.Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
A. Ferreiro-Iglesias et al.
PHARMACOGENOMICS JOURNAL (2016)
FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis
Cristina Lucia Davila-Fajardo et al.
PHARMACOGENOMICS (2015)
Variation at FCGR2A and Functionally Related Genes Is Associated with the Response to Anti-TNF Therapy in Rheumatoid Arthritis
Gabriela Avila-Pedretti et al.
PLOS ONE (2015)
Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population
Maria I. Zervou et al.
PLOS ONE (2013)
Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort
Darren Plant et al.
ARTHRITIS AND RHEUMATISM (2012)
Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity
Stephanie M. Stanford et al.
IMMUNOLOGY (2012)
Genetic polymorphism studies in periodontitis and Fcγ receptors
L. Chai et al.
JOURNAL OF PERIODONTAL RESEARCH (2012)
A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm
Paul P. Tak
RHEUMATOLOGY (2012)
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis
Carine Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis
Young Ho Lee et al.
MOLECULAR BIOLOGY REPORTS (2011)
Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis
Young Ho Lee et al.
MOLECULAR BIOLOGY REPORTS (2010)
Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to antitumour necrosis factor alpha therapy in rheumatoid arthritis
J. D. Canete et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Zehra Kaymakcalan et al.
CLINICAL IMMUNOLOGY (2009)
Differences in binding and effector functions between classes of TNF antagonists
Taruna Arora et al.
CYTOKINE (2009)
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk
Soumya Raychaudhuri et al.
NATURE GENETICS (2009)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
PADI4 polymorphisms and rheumatoid arthritis susceptibility:: a meta-analysis
Young Ho Lee et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Protein tyrosine phosphatases: from genes, to function, to disease
Nicholas K. Tonks
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Genome scan meta-analysis of rheumatoid arthritis
SJ Choi et al.
RHEUMATOLOGY (2006)
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints - Extended report
AI Catrina et al.
ARTHRITIS AND RHEUMATISM (2005)
Genomic organization of classical human low-affinity Fcγ receptor genes
K Su et al.
GENES AND IMMUNITY (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Share Paper
